Sernova Corp. on Twitter: "We are pleased to announce an exclusive global strategic partnership with @Evotec, which will enable us to advance a potential 'functional cure' for insulin-dependent #diabetes without supply constraints.
Can Sernova and Evotec's cell therapy approach result in a functional cure for diabetes?
Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays
Sernova (TSX.V: SVA): Changing the Standard of Care for Type 1 Diabetes Patients - YouTube
Does Sernova have a cure for Type 1 Diabetes? - InvestorIntel
Sernova recruits first subjects for its Cell Pouch diabetes clinical trial
Exciting update in Sernova's type 1 diabetes (T1D) trial | JDRF Canada
Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes | TechAlliance
Evotec und Sernova verkünden strategische Partnerschaft zur Entwicklung eines Diabetes-Medikaments ⋆ Das Managerblatt
Sernova - aussichtsreiche Studien-Highlights beflügeln den Kurs | Investing.com
Sernova | Dr. Piotr Witkowski | UChicago
Sernova and Evotec collaborate to develop cell therapy for diabetes
Sernova berichtet, dass den beiden ersten Patienten der zweiten Kohorte in der klinischen Phase-I/II-Studie zu Typ-1-Diabetes in den USA eine Cell Pouch implantiert wurde
Sernova Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data | World Pharma Today
How Sernova seeks to treat insulin-dependent diabetes
Sernova - Sernova is a regenerative medicine therapeutic technologies company creating long-term healthcare
Sernova gets under the skin | Evaluate
Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays
Sernova - TSX Life Sciences Investor Day - YouTube
Evotec Aktie mit Kaufempfehlung - Sernova macht Fortschritte bei Diabetes-Therapiekandidaten | 4investors
Illustration of the Sernova Cell Pouch™. A, Plugs in situ within the... | Download Scientific Diagram
Sernova touts first-in-human results from insulin-secreting cell implant for diabetes | Fierce Biotech
